FDA guidance provides new details on diversity action plans required for certain studies

U.S. FDA shared a post on X:

“Today, Food and Drug Administration issued a draft guidance to assist medical product sponsors in submitting Diversity Action Plans to support certain clinical studies.”

Devika Das, Medical Director at Parexel shared on X adding:

“Let us design and run trials that are equitable towards all of the population they are meant to serve. FDA issued guidance from today.”

Source: U.S. FDA/X and Devika Das/X